BIOMET INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-10-09: Form 8-K; Period of report 2014-10-09; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-07-09: Form 8-K; Period of report 2014-07-09; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-07-03: Form 8-K; Period of report 2014-07-02; Description 8.01 Other Events; Details 8.01.
- 2014-04-30: Form 8-K; Period of report 2014-04-24; Description 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-10-09 | 8-K | 2014-10-09 | 2.02 Results of Operations and Financial Condition | 2.02 The accompanying press release includes the accounts of Biomet, Inc. and its subsidiaries (individually and collectively referred to as “Biomet”, the “Company”, “we”, “us”, or “our”). | a8kq12015.htm |
| 2014-07-09 | 8-K | 2014-07-09 | 2.02 Results of Operations and Financial Condition | 2.02 The accompanying press release includes the accounts of Biomet, Inc. and its subsidiaries (individually and collectively referred to as “Biomet”, the “Company”, “we”, “us”, or “our”). | a7920148k.htm |
| 2014-07-03 | 8-K | 2014-07-02 | 8.01 Other Events | 8.01 As previously disclosed, on March 26, 2012, Biomet entered into a Deferred Prosecution Agreement, or DPA, with the Department of Justice, or DOJ, and a Consent to Final Judgment, or Consent, with the Securities and Exchange Commission, or SEC, regarding an investigation regarding possible violations of the Foreign Corrupt Practices Act. | d753648d8k.htm |
| 2014-04-30 | 8-K | 2014-04-24 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 5.02 (e) Compensatory Arrangements of Certain Officers. 8.01 On April 24, 2014, the Company issued a press release announcing the signing of the Merger Agreement, a copy of which is furnished as Exhibit 99.1. | d717269d8k.htm |
| 2014-04-14 | 8-K | 2014-04-11 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 2.02 The information set forth in Item 8.01 is incorporated herein by reference. 8.01 As described in the Quarterly Report on Form 10-Q jointly filed by LVB Acquisition, Inc. and Biomet, Inc. (together, the “Company”) on April 7, 2014 for the fiscal quarter ended February 28, 2014, the Company reclassified instrument depreciation from cost of sales to selling, general and administrative expense. | a8k4112014.htm |
| 2014-04-03 | 8-K | 2014-04-03 | 2.02 Results of Operations and Financial Condition | 2.02 The accompanying press release includes the accounts of Biomet, Inc. and its subsidiaries (individually and collectively referred to as “Biomet”, the “Company”, “we”, “us”, or “our”). | a4320148k.htm |
| 2014-03-07 | 8-K | 2014-03-06 | 8.01 Other Events | 8.01 On March 7, 2014, Biomet, Inc. announced that its parent company, LVB Acquisition, Inc., has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. | a8k362014.htm |
| 2014-02-21 | 8-K | 2014-02-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 14, 2014, Michael Dal Bello resigned from the Board of Directors, the Audit Committee of the Board of Directors and Compensation Committee of the Board of Directors of each of LVB Acquisition, Inc. and Biomet, Inc. (collectively, the “Company”). | a8k2182014.htm |
| 2014-02-04 | 8-K | 2014-02-03 | 8.01 Other Events | 8.01 On February 3, 2014, the Company issued a press release announcing the settlement of the Multi-District Litigation entitled MDL 2391 – In Re: Biomet M2A Magnum Hip Implant Product Liability Litigation. | d668899d8k.htm |
| 2014-01-08 | 8-K | 2014-01-08 | 2.02 Results of Operations and Financial Condition | 2.02 The accompanying press release includes the accounts of Biomet, Inc. and its subsidiaries (individually and collectively referred to as “Biomet”, the “Company”, “we”, “us”, or “our”). | a1820148k.htm |